002821.SZ
凯莱英
SZSE · Healthcare · C 制造业 · CN
CNY 156.57
−6.86%Year over year
Reported trailing growth
- Revenue
- +16.6%
- EBITDA
- —
- EBIT
- +11.6%
- EPS
- +10.2%
- Free cash flow
- -32.2%
- Operating cash flow
- +22.4%
Forward estimates
Based on analyst estimates
- Revenue
- -37.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -13.4%
- EBITDA
- -23.8%
- EBIT
- -29.7%
- Net income
- -30.0%
- EPS
- -29.5%
- Free cash flow
- -50.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026